Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bingliancao
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral (as Lozenge/tablet Form)
01
Overview
Bingliancao (冰莲草) is a traditional Chinese medicine herb used primarily in formulations such as "Bingliancao Guccal Tablets." It is employed in the treatment of recurrent minor aphthous ulcers (recurrent oral ulcers with gastrointestinal heat accumulation syndrome). The mechanism of action is not fully characterized in modern pharmacological terms but traditionally involves clearing heat and detoxifying effects according to Chinese medicine theory. Clinical trials are ongoing to evaluate its efficacy and safety for these indications. There is no detailed molecular mechanism or developer/manufacturer information widely available from standard pharmaceutical databases.
- Other names
- 冰莲草bing liancao
Beyond the preview
Go deeper on bingliancao.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bingliancao.